Phortress

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NamePhortress
Drug Alias Name5F-DF-203-L-lysinamideNSC-7103055F-203-prodrug
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA cross linking agentsCytochrome P450 stimulantsMitosis inhibitors +[4] 
TargetsCytochrome P450Aryl hydrocarbon receptorDNA
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of NottinghamPharminoxCancer Research UK
China Registration ClassN/A

Develop Information

Active CompaniesPharminoxUniversity Of NottinghamCancer Research UK
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A